Solta Medical has received Health Canada clearance for its second-generation LipoSonix system, designed for non-invasive waist circumference reduction.

The LipoSonix system uses high-intensity focused ultrasound technology to permanently destroy targeted fat beneath the skin.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The CE marked and FDA cleared LipoSonix system is expected to launch in the first quarter of 2012.

Solta Medical chairman president and CEO Stephen Fanning said the company also plans to expand commercial launch of the LipoSonix system in North America.

Medical Device Network Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Medical Device Network Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving medical devices advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now